These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chronic liver disease: the detection and characterization of circulating immune complexes. Brown SE, Steward MW, Viola L, Howard CR, Murray-Lyon IM. Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866 [Abstract] [Full Text] [Related]
9. Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers. Tiku ML, Beutner KR, Ogra PL. Clin Exp Immunol; 1979 Apr; 36(1):54-62. PubMed ID: 466862 [Abstract] [Full Text] [Related]
10. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. Safaie P, Poongkunran M, Kuang PP, Javaid A, Jacobs C, Pohlmann R, Nasser I, Lau DT. World J Gastroenterol; 2016 Mar 28; 22(12):3404-11. PubMed ID: 27022222 [Abstract] [Full Text] [Related]
13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients. Okuda H, Obata H, Motoike Y, Hisamitsu T. Hepatogastroenterology; 1984 Apr 28; 31(2):64-8. PubMed ID: 6202615 [Abstract] [Full Text] [Related]
14. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, Stazi MA, Bertin T, Crocè SL, Trande P. J Hepatol; 1992 Nov 28; 16(3):360-3. PubMed ID: 1336785 [Abstract] [Full Text] [Related]
17. Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test. Sansonno DE, Detomaso P, Primavera MV, Papanice MA, Donnaloia R, Manghisi OG. J Virol Methods; 1986 Sep 28; 14(2):141-51. PubMed ID: 3771731 [Abstract] [Full Text] [Related]
18. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer. Coursaget P, Barres JL, Tortey E, Cotty P, Diop T, Yvonnet B, Sow MT, Mboup S, Diop B, Bocande JE. Cancer Res; 1986 Mar 28; 46(3):1492-4. PubMed ID: 3943106 [Abstract] [Full Text] [Related]
19. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, Tsai JH. Br J Cancer; 1996 Jun 28; 73(12):1498-502. PubMed ID: 8664119 [Abstract] [Full Text] [Related]
20. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, Guttmann RD. Transplantation; 1987 Sep 28; 44(3):369-76. PubMed ID: 2820093 [Abstract] [Full Text] [Related] Page: [Next] [New Search]